Abstract
BACKGROUND: In patients with traumatic brain injury (TBI) requiring mechanical ventilation, ventilator-associated pneumonia (VAP) is a frequent and serious complication that often leads to prolonged hospitalization and increased mortality. However, reliable predictive tools for this specific patient population remain limited. This study aims to develop and validate an effective prediction model for VAP in TBI patients based on clinical variables. METHODS: We conducted a retrospective study using data from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. Univariate and multivariate logistic regression analyses were applied to identify independent predictors of VAP and to develop a nomogram. Model performance was assessed by receiver operating characteristic (ROC) curve analysis, calibration plots, and decision curve analysis (DCA). External validation was performed with clinical data from 43 TBI patients treated at the Third Affiliated Hospital of Anhui Medical University. RESULTS: Among 819 TBI patients admitted to the intensive care unit (ICU), 141 developed VAP. Four independent predictors of VAP were identified: sepsis, neuromuscular blocking agent (NMBA) use, ICU length of stay (LOS) and prothrombin time (PT). The nomogram demonstrated strong discriminative ability, with area under the curve (AUC) values of 0.800 [95% confidence interval (CI): 0.617-0.859] in the training cohort, 0.822 (95% CI: 0.621-0.929) in the testing cohort, and 0.711 (95% CI: 0.600-0.957) in the external validation cohort. The calibration curves demonstrated that the predictive model possesses satisfactory discriminative power with excellent model calibration. DCA revealed the nomogram's clinical utility across a probability threshold range of 5-45% for VAP intervention. CONCLUSIONS: We have developed and validated a predictive model for VAP in TBI patients. This high-performance tool can assist clinicians in early identification of high-risk cases and guide prevention strategies.